[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 11, Issue 5 (12-2009) ::
J Babol Univ Med Sci. 2009; Volume 11 Back to browse issues page
Effect of Clofibrate on Prolonged Jaundice of Term Neonates
Y Zahed pasha, * , M Ahmadpour Kacho , MH Lookzadeh , A Mazloomi
Abstract:   (86682 Views)
BACKGROUND AND OBJECTIVE: Fifteen to forty percent of neonates developed to prolonged jaundice. Several therapeutic modalities have been used for the treatment of prolonged jaundice. This study was carried out to evaluate the effect of clofibrate on prolong jaundice in full term neonates.
METHODS: This double blind clinical trial study was done on 56 neonates that divided randomly in two groups. Treatment group received clofibrate 100mg/kg by oral and control group received sterile water. Inclusion criteria were term neonates with prolonged jaundice (bilirubin concentration higher than 10 mg/dl) in neonates older than 14 days old). All babies were fed exclusively by their own mothers milk. Exclusion criteria were using of phenobarbital or traditional medicine and neonates with clinical and paraclinical sign of liver disease or direct hyperbilirobinemia above 1.5 mg. Bilirubin concentrations were measured before and 72 hours after treatment and compared in both groups.
FINDINGS: Distribution of sex, blood group and Rh in mother and neonate and mean of age, birth weight, hematocrit and hemoglobin showed no significant difference before intervention between two groups. The mean level (mg/dl) of indirect bilirubin (11.7±1.4 in control and 12.4±1.6 in case) and direct bilirubin (0.4±0.1 in control and 0.5±0.1 in case) wasn significant difference between two groups before treatment, but the mean level of indirect bilirubin after treatment in case (8.4±1.8) was significantly lower than control (10.4±2) (p=0.000). The mean level of direct bilirubin after treatment showed no significant difference between case (0.4±0.1) and control (0.5±0.1).
CONCLUSION: Clofibrate is an effective agent in reduction of serum bilirubin level in term healthy neonates with prolonged jaundice.
Keywords: Clofibrate, Prolonged jaundice, Neonate, Hyperbilirubinemia
Full-Text [PDF 779 kb]   (2128 Downloads)    
Type of Study: Research | Subject: Biochemical
Accepted: 2014/06/4 | Published: 2014/06/4


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zahed pasha, Y, Ahmadpour Kacho M, Lookzadeh M, Mazloomi A. Effect of Clofibrate on Prolonged Jaundice of Term Neonates. J Babol Univ Med Sci 2009; 11 (5) :22-26
URL: http://jbums.org/article-1-3357-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 5 (12-2009) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.05 seconds with 43 queries by YEKTAWEB 4645